‘Needle-Free’ Bird Flu Vaccine Trial Begins in Australia With US Backing

Participants dosed with the vaccine will be tested for their response to ‘pre-pandemic avian influenza strain H7N9.’

A person holds a test tube labelled "Bird Flu", in this picture illustration, on January 14, 2023. REUTERS/Dado Ruvic/Illustration/File Photo

An Australian and U.S. biotech company will trial a new bird flu vaccine that does not require a needle for injection.

Vaxxas will conduct the clinical study at multiple Australian clinical sites with oversight from the U.S. Biomedical Advanced Research and Development Authority (BARDA).